ENVVENO MEDICAL CORPORATION's ticker is and the CUSIP is 29415J106. A total of 24 filers reported holding ENVVENO MEDICAL CORPORATION in Q1 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $16,848 | -4.6% | 3,278 | 0.0% | 0.01% | -12.5% |
| Q3 2023 | $17,667 | +75.0% | 3,278 | 0.0% | 0.01% | +100.0% |
| Q2 2023 | $10,095 | -34.2% | 3,278 | 0.0% | 0.00% | -42.9% |
| Q1 2023 | $15,340 | -8.2% | 3,278 | 0.0% | 0.01% | -22.2% |
| Q4 2022 | $16,716 | -18.8% | 3,278 | 0.0% | 0.01% | -25.0% |
| Q3 2022 | $20,584 | +66.1% | 3,278 | 0.0% | 0.01% | +71.4% |
| Q2 2022 | $12,390 | -40.7% | 3,278 | 0.0% | 0.01% | -30.0% |
| Q1 2022 | $20,879 | -3.3% | 3,278 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $21,600 | – | 3,278 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 653,870 | $3,432,818 | 0.37% |
| ADAR1 Capital Management, LLC | 201,728 | $1,059,072 | 0.20% |
| Nantahala Capital Management | 477,855 | $2,508,739 | 0.15% |
| Perceptive Advisors | 623,315 | $3,272,404 | 0.08% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 230,790 | $1,211,648 | 0.08% |
| Westside Investment Management, Inc. | 38,762 | $203,505 | 0.05% |
| Fermata Advisors, LLC | 30,949 | $162,482 | 0.04% |
| Laird Norton Wetherby Trust Company, LLC | 33,000 | $173,250 | 0.02% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 14,000 | $73,500 | 0.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 139,774 | $733,935 | 0.00% |